- Home
- AVIR vs MCR Comparison
AVIR vs MCR Comparison
Compare AVIR & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- MCR
- Stock Information
- Founded
- AVIR 2012
- MCR 1989
- Country
- AVIR United States
- MCR United States
- Employees
- AVIR N/A
- MCR N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- MCR Trusts Except Educational Religious and Charitable
- Sector
- AVIR Health Care
- MCR Finance
- Exchange
- AVIR Nasdaq
- MCR Nasdaq
- Market Cap
- AVIR 276.9M
- MCR 263.0M
- IPO Year
- AVIR 2020
- MCR N/A
- Fundamental
- Price
- AVIR $3.25
- MCR $6.23
- Analyst Decision
- AVIR Hold
- MCR
- Analyst Count
- AVIR 1
- MCR 0
- Target Price
- AVIR $6.88
- MCR N/A
- AVG Volume (30 Days)
- AVIR 178.7K
- MCR 66.7K
- Earning Date
- AVIR 11-07-2024
- MCR 01-01-0001
- Dividend Yield
- AVIR N/A
- MCR 8.52%
- EPS Growth
- AVIR N/A
- MCR N/A
- EPS
- AVIR N/A
- MCR 0.38
- Revenue
- AVIR N/A
- MCR N/A
- Revenue This Year
- AVIR N/A
- MCR N/A
- Revenue Next Year
- AVIR N/A
- MCR N/A
- P/E Ratio
- AVIR N/A
- MCR $16.61
- Revenue Growth
- AVIR N/A
- MCR N/A
- 52 Week Low
- AVIR $2.81
- MCR $5.63
- 52 Week High
- AVIR $4.60
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- AVIR 44.03
- MCR 39.38
- Support Level
- AVIR $3.10
- MCR $6.16
- Resistance Level
- AVIR $3.48
- MCR $6.42
- Average True Range (ATR)
- AVIR 0.13
- MCR 0.06
- MACD
- AVIR -0.01
- MCR -0.01
- Stochastic Oscillator
- AVIR 29.52
- MCR 29.63
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.